• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

异基因干细胞移植受者侵袭性真菌感染的危险因素及预后:单中心经验

Risk factors and prognosis of invasive fungal infections in allogeneic stem cell transplantation recipients: a single-institution experience.

作者信息

Zhang P, Jiang E-L, Yang D-L, Yan Z-S, Huang Y, Wei J-L, Wang M, Ma Q-L, Liu Q-G, Zou D-H, He Y, Qiu L-G, Feng S-Z, Han M-Z

机构信息

Hematopoietic Stem Cell Transplantation Center, Institute of Hematology & Blood Disease Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, Tianjin, China.

出版信息

Transpl Infect Dis. 2010 Aug 1;12(4):316-21. doi: 10.1111/j.1399-3062.2010.00497.x. Epub 2010 Feb 17.

DOI:10.1111/j.1399-3062.2010.00497.x
PMID:20180926
Abstract

OBJECTIVE

Invasive fungal infections (IFI) are frequent complications of allogeneic hematopoietic stem cell transplantation (SCT) and major causes of a poor prognosis. Analysis of risk factors and prognosis of IFI are important for the control of IFI.

PATIENTS AND METHODS

We retrospectively reviewed the medical records of all allogeneic SCT recipients from January 2000 to December 2007. For the homogeneity of analysis, only 286 patients with no history of IFI were included.

RESULTS

Fifty-five cases of IFI were identified, corresponding to cumulative incidence of 19.8%. Different overall survival rates were recorded in patients with or without IFI (20.3% vs. 55.3%, P=0.004). Multivariate analysis identified 2 risk factors of IFI: use of high-dose steroid and cytomegalovirus infections, and risk stratification can classify the patients into 3 subgroups with different incidences of IFI (9.2%, 25.4%, and 34.1%, P=0.0007). Further analysis confirmed use of steroid as a risk factor of inferior prognosis in IFI cases (0 vs. 57.1%, P<0.0001), which was due to higher rates of IFI-related mortality (64.7% vs. 23.9%, P=0.018).

CONCLUSION

Post-transplant IFI was an unfavorable prognostic factor of the SCT recipients, and risk stratification can identify patients with high risk of IFI. Use of steroid played an important role in the pathogenesis as well as prognosis of IFI.

摘要

目的

侵袭性真菌感染(IFI)是异基因造血干细胞移植(SCT)常见的并发症,也是预后不良的主要原因。分析IFI的危险因素和预后对控制IFI具有重要意义。

患者与方法

我们回顾性分析了2000年1月至2007年12月期间所有异基因SCT受者的病历。为保证分析的同质性,仅纳入286例无IFI病史的患者。

结果

共确诊55例IFI,累积发病率为19.8%。有或无IFI的患者总生存率不同(20.3%对55.3%,P = 0.004)。多因素分析确定了IFI的2个危险因素:使用大剂量类固醇和巨细胞病毒感染,风险分层可将患者分为3个IFI发病率不同的亚组(9.2%、25.4%和

相似文献

1
Risk factors and prognosis of invasive fungal infections in allogeneic stem cell transplantation recipients: a single-institution experience.异基因干细胞移植受者侵袭性真菌感染的危险因素及预后:单中心经验
Transpl Infect Dis. 2010 Aug 1;12(4):316-21. doi: 10.1111/j.1399-3062.2010.00497.x. Epub 2010 Feb 17.
2
[The clinical characteristic and risk factors for the incidence of invasive fungal infection in patients following allogeneic hematopoietic stem cell transplantation].[异基因造血干细胞移植患者侵袭性真菌感染发生的临床特征及危险因素]
Zhonghua Yi Xue Za Zhi. 2009 Nov 3;89(40):2814-7.
3
Risks and outcomes of invasive fungal infections in pediatric patients undergoing allogeneic hematopoietic cell transplantation.接受异基因造血细胞移植的儿科患者侵袭性真菌感染的风险与结局
Bone Marrow Transplant. 2005 Oct;36(7):621-9. doi: 10.1038/sj.bmt.1705113.
4
Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study--Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne.造血干细胞移植受者的真菌感染:SEIFEM B - 2004研究结果——恶性血液病真菌性感染的流行病学监测
Clin Infect Dis. 2007 Nov 1;45(9):1161-70. doi: 10.1086/522189. Epub 2007 Sep 26.
5
Invasive fungal infections in pediatric bone marrow transplant recipients: single center experience of 10 years.儿童骨髓移植受者侵袭性真菌感染:单中心10年经验
Bone Marrow Transplant. 2000 Nov;26(9):999-1004. doi: 10.1038/sj.bmt.1702654.
6
Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database.2001-2006 年造血干细胞移植受者侵袭性真菌感染的前瞻性监测:移植相关感染监测网络(TRANSNET)数据库概述。
Clin Infect Dis. 2010 Apr 15;50(8):1091-100. doi: 10.1086/651263.
7
Voriconazole is safe and effective as prophylaxis for early and late fungal infections following allogeneic hematopoietic stem cell transplantation.伏立康唑作为异基因造血干细胞移植后早期和晚期真菌感染的预防用药是安全有效的。
Transpl Infect Dis. 2010 Feb;12(1):45-50. doi: 10.1111/j.1399-3062.2009.00455.x. Epub 2009 Sep 30.
8
Randomized PCR-based therapy and risk factors for invasive fungal infection following reduced-intensity conditioning and hematopoietic SCT.随机聚合酶链反应为基础的治疗和危险因素的侵袭性真菌感染后,减少强度调理和造血干细胞移植。
Bone Marrow Transplant. 2010 Dec;45(12):1710-8. doi: 10.1038/bmt.2010.38. Epub 2010 Mar 1.
9
Invasive fungal disease in allogeneic hematopoietic stem cell transplant recipients: an autopsy-driven survey.异基因造血干细胞移植受者的侵袭性真菌病:一项尸检驱动的调查。
Transpl Infect Dis. 2008 Apr;10(2):106-9. doi: 10.1111/j.1399-3062.2007.00264.x. Epub 2007 Jul 1.
10
[Invasive mycoses during hematopoietic stem cell transplantation].造血干细胞移植期间的侵袭性真菌病
Ter Arkh. 2012;84(7):50-7.

引用本文的文献

1
Effectiveness of posaconazole as primary prophylaxis in allogeneic hematopoietic stem cell transplantation.泊沙康唑作为异基因造血干细胞移植主要预防用药的有效性
Int J Hematol. 2025 Sep 3. doi: 10.1007/s12185-025-04059-0.
2
When Viruses Meet Fungi: Tackling the Enemies in Hematology.当病毒遇上真菌:应对血液学中的敌人
J Fungi (Basel). 2022 Feb 13;8(2):184. doi: 10.3390/jof8020184.
3
A Reference Laboratory Surveillance on Fungal Isolates from Patients with Haematological Malignancy in Japan.日本血液系统恶性肿瘤患者真菌分离株的参考实验室监测
J Fungi (Basel). 2021 Sep 27;7(10):806. doi: 10.3390/jof7100806.
4
Association between CMV and Invasive Fungal Infections After Autologous Stem Cell Transplant in Lymphoproliferative Malignancies: Opportunistic Partnership or Cause-Effect Relationship?CMV 与淋巴增生性恶性肿瘤自体干细胞移植后侵袭性真菌感染的关系:机会性伙伴关系还是因果关系?
Int J Mol Sci. 2019 Mar 19;20(6):1373. doi: 10.3390/ijms20061373.
5
[Diagnostic value of the lung biopsy in hemotologic patients with invasive fungal disease].肺活检在血液系统侵袭性真菌病患者中的诊断价值
Zhonghua Xue Ye Xue Za Zhi. 2018 Feb 14;39(2):159-161. doi: 10.3760/cma.j.issn.0253-2727.2018.02.017.
6
Fulminant Laryngeal-tracheobronchial-pulmonary Aspergillosis: A Rare and Fatal Complication in Allogeneic Hematopoietic Stem Cell Transplantation Recipients.暴发性喉气管支气管肺曲霉病:异基因造血干细胞移植受者中一种罕见且致命的并发症
Intern Med. 2017;56(3):347-351. doi: 10.2169/internalmedicine.56.7201. Epub 2017 Feb 1.
7
Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016.2016年异基因造血干细胞移植中的感染性疾病:预防与预防策略指南
Ann Hematol. 2016 Sep;95(9):1435-55. doi: 10.1007/s00277-016-2711-1. Epub 2016 Jun 24.
8
Recommendations for Risk Categorization and Prophylaxis of Invasive Fungal Diseases in Hematological Malignancies: A Critical Review of Evidence and Expert Opinion (TEO-4).血液系统恶性肿瘤侵袭性真菌病的风险分类与预防建议:证据与专家意见的批判性综述(TEO-4)
Turk J Haematol. 2015 Jun;32(2):100-17. doi: 10.4274/tjh.2014.0277.
9
Incidence and risk factors of post-engraftment invasive fungal disease in adult allogeneic hematopoietic stem cell transplant recipients receiving oral azoles prophylaxis.接受口服唑类药物预防的成年异基因造血干细胞移植受者移植后侵袭性真菌病的发病率及危险因素
Bone Marrow Transplant. 2015 Nov;50(11):1465-72. doi: 10.1038/bmt.2015.181. Epub 2015 Aug 17.
10
Invasive fungal infection in patients receiving chemotherapy for hematological malignancy: a multicenter, prospective, observational study in China.血液系统恶性肿瘤化疗患者侵袭性真菌感染:一项中国多中心、前瞻性、观察性研究
Tumour Biol. 2015 Feb;36(2):757-67. doi: 10.1007/s13277-014-2649-7. Epub 2014 Oct 8.